Biotechnology Analysis & Statistics, January 2015 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

271-300 of about 4 000 reports

Purchase Reports From Reputable Market Research Publishers

Kerry Group in Ingredients (World)

Kerry Group in Ingredients (World)

  • $ 532
  • Company report
  • January 2015
  • by Euromonitor International

Kerry’s Ingredients & Flavours division is a significant force in many different areas of the global ingredients market, which means that it is ideally placed to deliver complete solutions for its customers. ...

  • Countries : Asia, World
Pharmaceutical Sector in India - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Pharmaceutical Sector in India - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Pharmaceutical Sector in India. In depth profile includes; - Overview of Pharmaceuticals and Biotech Sector in India - Insights into the key drivers and challenges ...

  • Industries : Pharmaceutical
  • Countries : India
Biotech Market in Korea - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Biotech Market in Korea - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Biotech current market scenario, structure and practices in Korea. In depth market scenario includes; - Key Biotech segments - Medical biotech, Agriculture biotech, ...

  • Industries : Biotechnology
  • Countries : South Korea
Biotech Market in Taiwan - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Biotech Market in Taiwan - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Biotech current market scenario, structure and practices in Taiwan. In depth market scenario includes; - Key Biotech segments - Medical biotech, Agriculture biotech, ...

  • Industries : Biotechnology
  • Countries : Taiwan
Biotech Market in China - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Biotech Market in China - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Biotech current market scenario, structure and practices in China. In depth market scenario includes; - Key Biotech segments - Medical biotech, Agriculture biotech, ...

  • Industries : Biotechnology
  • Countries : China
Biotech Market in Malaysia - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Biotech Market in Malaysia - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Biotech current market scenario, structure and practices in Malaysia. In depth market scenario includes; - Key Biotech segments - Medical biotech, Agriculture biotech, ...

  • Industries : Biotechnology
  • Countries : Malaysia
Biotech Market in Philippines - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Biotech Market in Philippines - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Biotech current market scenario, structure and practices in Philippines. In depth market scenario includes; - Key Biotech segments - Medical biotech, Agriculture ...

  • Industries : Biotechnology
  • Countries : Philippines
Cooper Cos Inc , The in Eyewear (World)

Cooper Cos Inc , The in Eyewear (World)

  • $ 532
  • Company report
  • January 2015
  • by Euromonitor International

CooperVision, the vision care unit of The Cooper Cos Inc, has carved a niche for itself in toric and multifocal lenses. Having grown rapidly over the years, it is now looking to compete more aggressively ...

  • Countries : World, United States
Competitor Analysis: VEGF & VEGF-R Antibodies 2015 – Biosimilars and Biosuperiors of Avastin and Lucentis

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 – Biosimilars and Biosuperiors of Avastin and Lucentis

  • $ 486
  • Industry report
  • February 2015
  • by La Merie Publishing

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 – Biosimilars and Biosuperiors of Avastin and Lucentis This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and ...

  • Industries : Biopharmaceutical
Vital Signs - The Analyst%s Perspective - January 2015 Issue

Vital Signs - The Analyst%s Perspective - January 2015 Issue

  • $ 450
  • Industry report
  • February 2015
  • by Frost & Sullivan

This issue of Vital Signs, released on February 4, 2014, discusses Roche's collaboration with Foundation Medicine, Novartis' potential anti-aging drug, and DNA Electronics; acquisition of nanoMR, Inc.

  • Industries : Genomics
Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

  • $ 412
  • Industry report
  • February 2015
  • by La Merie Publishing

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides ...

  • Industries : Biopharmaceutical
Analysis of Agenus Inc

Analysis of Agenus Inc

  • $ 300
  • Industry report
  • March 2015
  • by Aruvian's R'search

Agenus Inc. is a pharmaceutical manufacturing company that is involved in the development of a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines and adjuvants for the ...

  • Industries : Pathology
  • Countries : United States
Analysis of Amgen Inc.

Analysis of Amgen Inc.

  • $ 300
  • Industry report
  • March 2015
  • by Aruvian's R'search

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and delivers human therapeutics based on advances in cellular and molecular biology primarily in the United States, Europe, ...

  • Industries : Pathology
  • Countries : United States
Analysis of Genentech, Inc.

Analysis of Genentech, Inc.

  • $ 300
  • Industry report
  • March 2015
  • by Aruvian's R'search

Genentech, Inc., an independent subsidiary of Roche Holding, is a leading biotech company headquartered in California, United States. The company's primary focus is on developing drugs for medical conditions ...

  • Industries : Pathology
  • Countries : United States
TCM Biotech International Corp (4169) - Financial and Strategic SWOT Analysis Review

TCM Biotech International Corp (4169) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary TCM Biotech International Corp (TCM Biotech) is a biotechnology company. The company research and develops botanic drugs, health food and functional ingredients. It offers various pharmaceutical ...

  • Industries : Biotechnology
IDL Biotech AB (IDL B) - Financial and Strategic SWOT Analysis Review

IDL Biotech AB (IDL B) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary IDL Biotech AB (IDL Biotech) is a diagnostic company. The company develops, manufactures and markets in vitro diagnostic tests for healthcare industry. It offers diagnostics for oncology and diagnostics ...

  • Industries : Biotechnology
Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Kane Biotech Inc. (Kane Biotech) is a biotechnology company. The company develops and commercializes products that prevent and remove microbial biofilms. It uses patent protected technology based ...

  • Industries : Biotechnology
Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review

Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Golden Biotechnology Corp. (Golden Biotech) is a biotechnology company. The company develops and commercializes drugs and herbal supplements to prevent and treat diseases. It discovers new drugs ...

  • Industries : Biotechnology
XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary XTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical ...

  • Industries : Biopharmaceutical
Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Entest BioMedical, Inc. (Entest BioMedical) is a biomedical research company. The company develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human ...

  • Industries : Biopharmaceutical
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. ...

  • Industries : Biopharmaceutical
Krebs Biochemicals & Industries Ltd (524518) - Financial and Strategic SWOT Analysis Review

Krebs Biochemicals & Industries Ltd (524518) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Krebs Biochemicals & Industries Ltd (KBIL) is a pharmaceutical company. The company manufactures and markets painkillers, anti-asthmatic and anti-HIV drugs for the healthcare market. Its products ...

  • Industries : Biotechnology, Drug and Medication
Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review

Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Iris BioTechnologies Inc. (Iris BioTechnologies) is a biotechnology company. It focuses on the development and commercialization of Nano-Biochips and an artificial intelligence system, which assists ...

  • Industries : Biotechnology
Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Kythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States
Maxigen Biotech Inc. (1783) - Financial and Strategic SWOT Analysis Review

Maxigen Biotech Inc. (1783) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Maxigen Biotech Inc. (MBI) is a biotechnology company. The company focuses on developing, manufacturing and marketing orthopedic, ophthalmic, dental medical devices and skincare products. It opereates ...

  • Industries : Biotechnology
PharmaCyte Biotech, Inc. (NVLX) - Financial and Strategic SWOT Analysis Review

PharmaCyte Biotech, Inc. (NVLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary PharmaCyte Biotech, Inc., formerly, Nuvilex, Inc. (PharmaCyte) is a biotechnology company. The company operates with live-cell encapsulation technology to enclose living cells in protective cocoons ...

  • Industries : Biotechnology
DR. Chip Biotech Inc. (4131) - Financial and Strategic SWOT Analysis Review

DR. Chip Biotech Inc. (4131) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary DR. Chip Biotech Inc. (DR. Chip) is a biotechnology company. The company develops and markets biochips, image analysis devices and software, and biological reagents for medical diagnosis and research ...

  • Industries : Biotechnology
NanoCarrier Co., Ltd. (4571) - Financial and Strategic SWOT Analysis Review

NanoCarrier Co., Ltd. (4571) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary NanoCarrier Co., Ltd. (NanoCarrier) is a biotechnology company. The company researches, develops and produces pharmaceuticals using micellar nanoparticles technology. It develops drugs in the field ...

  • Industries : Biotechnology
Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review

Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Level Biotechnology Inc. (LBI) is a biotechnology company. The company markets and distributes cell culture, molecular biology products, immunology and biomedical precision equipments. Its products ...

  • Industries : Biotechnology
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops parthenogenesis, a stem cell technology that advances the field of regenerative medicine. It develops ...

  • Industries : Biological Therapy

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.